J. Lopez-Sandoval S. et al. (2018) reported that a higher level of inflammatory markers and low plasma adiponectin levels in obese adolescents can be at high risk for the development of CHD and T2DM [35]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.